Rong Li
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Cancer-related Molecular Pathways
Papers in
-
- Cancer, Hypoxia, and Metabolism 23
- MicroRNA in disease regulation 19
- Oncology 118
- Cancer Cells and Metastasis 21
- Lung Cancer Research Studies 19
- Cancer Immunotherapy and Biomarkers 18
Rong Li
429 papers receiving 8.6k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Cancer Research 1.5k
- Oncology 2.2k
- Molecular Biology 4.5k
- Immunology 758
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by Rong Li
This map shows the geographic impact of Rong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Li more than expected).
Fields of papers citing papers by Rong Li
This network shows the impact of papers produced by Rong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Li. The network helps show where Rong Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 4 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 12 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 54 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 0 | |
| 16 | 2023 | 3 | |
| 17 | 2023 | 6 | |
| 18 | 2023 | 14 | |
| 19 | 2022 | 10 | |
| 20 | 2009 | 20 |
About Rong Li
Rong Li is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Physiology, having authored 454 papers that have together received 8.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (39 papers), RNA modifications and cancer (36 papers), Cancer, Hypoxia, and Metabolism (23 papers), Cancer Cells and Metastasis (21 papers), MicroRNA in disease regulation (19 papers), Lung Cancer Research Studies (19 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Lysosomal Storage Disorders Research (17 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (2.2k citations), Molecular Biology (4.5k citations), Immunology (758 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Rong Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bruce Stillman, Gregory J. Hannon, David Beach, S Waga, Lixin Wei, Cui‐Fen Hu, Xian Jin, Chengxing Shen, Liang Liu and Zhong’e Zhou. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, Tumor Biology, Stem Cell Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.